How it works
The material is first frozen, locking its water as ice. Under vacuum, that ice sublimes — passing straight from solid to vapour — so the peptide is never exposed to a warm, concentrated solution, the conditions under which many peptides degrade.
The result is a porous, low-moisture solid. Because most of the water is gone, a lyophilized powder is generally more stable in storage and transit than the same peptide in solution — one reason research peptides are supplied dry.
Lyophilization is a physical process, not a chemical one. It changes the material’s form and water content, not its identity: the molecular formula and mass of the dried peptide are the same as in solution.
Why it matters
Supplying a peptide as a lyophilate is a stability decision. The dry form is what the storage and shipping conditions on a compound page are written for, and it is why cold-chain handling is a separate, downstream concern.
Because a lyophilate holds some residual water, drying quality ties to other measurements — water is mass, so a well-dried powder is also a precondition for a clean mass measurement.
It shapes handling without changing chemistry. The dry form is what the stated storage conditions apply to; material in solution is less stable than the same peptide held dry.
At Lineará
Lineará compounds are supplied as lyophilized powders; each compound page states the physical form, storage, and solubility the material was characterized to hold.
The dry form is the reason handling guidance is written as cold-chain storage and transit conditions — covered as handling, never as use protocols.